Eleven Biotherapeutics Reports Fourth Quarter and Full Year 2015 Financial Results and Provides Strategic Update
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Eleven continues to advance its internal pipeline, including EBI-031, which remains on target for a second quarter 2015 IND submission.
